title: [Recommendations for the prevention of respiratory syncytial virus in high-risk pediatric groups].
authors: Institut za zdravstvenu zastitu majke i deteta Srbije, Dr Vukan Cupić, Beograd, Srbija.; tUniverzitetska derija klinika, Beograd, Srbija; *Institut za neonatologiju, Beograd, Srbija. borisav.jan@sbb.rs
authors: Borisav
authors: B
authors: Janković
authors: Predrag
authors: P
authors: Minić
authors: Svjetlana
authors: S
authors: Maglajlić-Djukić
authors: Niveska
authors: N
authors: Prekajski
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012307:Risk Factors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab